Event
VIth International Drug Discovery and Development Forum
Thursday, December 10, 2020toFriday, December 11, 2020
“Advances in molecular diagnostics and new approaches in drug discovery”
The program will include speakers from Australia, Germany, United Kingdom, United States and Canada.
Day I will focus on molecular diagnostics with an emphasis on metabolomics. Topics:
- The metabolic legacy of SARS-CoV2 (Prof. Elaine Holmes, Australia)
- Metabolomics of cardiometabolic diseases: potential markers of pre-morbidities for Covid-19 (Prof. Marc-Emmanuel Dumas, United Kingdom)
- NMR Based Tools for Clinical and Translational Research (Dr. Manfred Spraul, Bruker, Germany)
- Metabolomics: from raw LC-MS spectra to biological insights (Prof. Jianguo (Jeff) Xia, ۲ݮƵ, Canada)
Day II will focus on new approaches in drug discovery and the FDA-approved Covid-19 drug remdesivir. Topics:
- Early drug discovery in industry and drugging the cancer genome (Dr. Thomas Hudson, Vice-President Abbvie USA & Prof. Vincent Mooser, Canada Excellence Research Chair in Genomic Medicine, ۲ݮƵ, Canada)
- Design of Proteolysis Targeting Chimera – PROTACs (Prof. Craig Crews, Yale University, USA)
- Breakthrough work on the Covid-19 remdesivir drug (Prof. Matthias Götte, University of Alberta, Canada)
- Selected topics for trainee presentations.
For more info and registration, click .